Fideuram Intesa Sanpaolo Private Banking S.P.A. Takes $5.50 Million Position in HCA Healthcare, Inc. $HCA

Fideuram Intesa Sanpaolo Private Banking S.P.A. bought a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 11,777 shares of the company’s stock, valued at approximately $5,498,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Tredje AP fonden purchased a new stake in shares of HCA Healthcare in the 4th quarter valued at $6,121,000. Larson Financial Group LLC increased its position in shares of HCA Healthcare by 13.5% during the fourth quarter. Larson Financial Group LLC now owns 805 shares of the company’s stock worth $376,000 after acquiring an additional 96 shares during the period. Handelsbanken Fonder AB increased its position in shares of HCA Healthcare by 7.9% during the fourth quarter. Handelsbanken Fonder AB now owns 213,272 shares of the company’s stock worth $99,568,000 after acquiring an additional 15,675 shares during the period. Hartford Funds Management Co LLC increased its position in shares of HCA Healthcare by 56.0% during the fourth quarter. Hartford Funds Management Co LLC now owns 4,440 shares of the company’s stock worth $2,075,000 after acquiring an additional 1,593 shares during the period. Finally, Profund Advisors LLC increased its position in shares of HCA Healthcare by 25.4% during the fourth quarter. Profund Advisors LLC now owns 2,783 shares of the company’s stock worth $1,299,000 after acquiring an additional 564 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Down 4.4%

NYSE:HCA opened at $403.98 on Wednesday. The company has a market capitalization of $89.62 billion, a PE ratio of 13.89, a P/E/G ratio of 1.34 and a beta of 1.18. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52. The stock’s 50 day moving average price is $473.90 and its 200 day moving average price is $485.20.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The business had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts anticipate that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is 10.73%.

Analyst Ratings Changes

HCA has been the topic of several analyst reports. Jefferies Financial Group reaffirmed a “buy” rating and issued a $525.00 target price on shares of HCA Healthcare in a report on Friday, April 24th. JPMorgan Chase & Co. decreased their price target on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a report on Tuesday. Mizuho lifted their price target on HCA Healthcare from $540.00 to $585.00 and gave the stock an “outperform” rating in a report on Wednesday, February 25th. Wall Street Zen downgraded HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Finally, Oppenheimer lowered their target price on shares of HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $515.77.

HCA Healthcare Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.